Last $22.54 USD
Change Today -1.30 / -5.45%
Volume 23.8K
AIQ On Other Exchanges
Symbol
Exchange
NASDAQ GM
Berlin
As of 4:30 PM 01/30/15 All times are local (Market data is delayed by at least 15 minutes).

alliance healthcare service (AIQ) Snapshot

Open
$23.55
Previous Close
$23.84
Day High
$24.24
Day Low
$22.53
52 Week High
03/28/14 - $35.40
52 Week Low
12/16/14 - $18.92
Market Cap
242.0M
Average Volume 10 Days
25.1K
EPS TTM
$1.34
Shares Outstanding
10.7M
EX-Date
--
P/E TM
16.9x
Dividend
--
Dividend Yield
--
Current Stock Chart for ALLIANCE HEALTHCARE SERVICE (AIQ)

Related News

No related news articles were found.

alliance healthcare service (AIQ) Related Businessweek News

No Related Businessweek News Found

alliance healthcare service (AIQ) Details

Alliance HealthCare Services, Inc., together with its subsidiaries, provides outpatient diagnostic imaging and radiation therapy services in the United States. The company operates through Imaging and Radiation Oncology segments. Its diagnostic imaging services include magnetic resonance imaging (MRI) technology and positron emission tomography/computed tomography (PET/CT) that generate representations of the internal anatomy and convert them to film or digital media; nuclear medicine or gamma camera, ultrasound, mammography, bone densitometry, general X-Ray technologies; and non scan-based services. The company also offers radiation oncology services, such as conventional beam therapy, 3-D conformal radiation therapy, intensity modulated radiation therapy, image guided radiation therapy, stereotactic radiosurgery and stereotactic body radiotherapy, and low dose rate and high dose rate brachytherapy for the treatment of cancer. In addition, it provides ancillary services, such as marketing support, education, training, and billing assistance. The company offers imaging and therapeutic services to hospitals and other healthcare providers on a shared-service and full-time service basis, as well as provides services through fixed-sites, primarily to hospitals or health systems. As of December 31, 2013, Alliance HealthCare Services, Inc. had 449 diagnostic imaging and 42 radiation oncology systems, including 263 MRI systems, 122 PET or PET/CT systems, 22 CT systems, 9 ultrasound systems, and 33 other imaging systems, as well as operated 125 fixed-site imaging centers, and 28 radiation oncology centers and stereotactic radiosurgery facilities. Alliance HealthCare Services, Inc. was founded in 1983 and is headquartered in Newport Beach, California.

1,504 Employees
Last Reported Date: 03/13/14
Founded in 1983

alliance healthcare service (AIQ) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $434.6K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $349.8K
President of Alliance Radiology
Total Annual Compensation: $356.3K
Executive Vice President, General Counsel and...
Total Annual Compensation: $385.9K
Compensation as of Fiscal Year 2013.

alliance healthcare service (AIQ) Key Developments

Alliance Healthcare Services, Inc. Announces Unaudited Consolidated Financial Results for the Third Quarter and Nine Months Ended September 30, 2014; Revised Earnings Guidance for the Year of 2014; Reports Impairment Charges for the Third Quarter Ended September 30, 2014

Alliance Healthcare Services, Inc. announced unaudited consolidated financial results for the third quarter and nine months ended September 30, 2014. For the quarter, the company reported revenues of $110.137 million against $113.375 million a year ago. Income before income taxes, earnings from unconsolidated investees, and noncontrolling interest was $9.583 million against loss before income taxes, earnings from unconsolidated investees, and noncontrolling interest of $2.407 million a year ago. Net income attributable to the company was $4.011 million or $0.37 per diluted share against net loss attributable to the company $2.070 million or $0.19 per diluted share a year ago. Net income was $7.854 million against $1.332 million a year ago. Adjusted EBITDA was $34.953 million against $38.556 million a year ago. Net income on a diluted basis, computed in accordance with GAAP, increased to $0.37 per share in the third quarter of 2014 compared to loss of $0.19 per share for the same quarter of 2013. Net loss per share on a diluted basis was impacted by $0.15 in the third quarter of 2014 and $0.60 in the third quarter of 2013 in the aggregate due to restructuring charges, severance and related costs, transaction costs, legal matter expenses and differences in the GAAP income tax rate from historical income tax rate. Cash flows provided by operating activities totaled $26.1 million in the third quarter of 2014 compared to $32.6 million in the third quarter of 2013. In the third quarter of 2014, capital expenditures were $9.9 million compared to $8.7 million in the third quarter of 2013. For the nine months, the company reported revenues of $326.740 million against $338.175 million a year ago. Income before income taxes, earnings from unconsolidated investees, and noncontrolling interest was $22.452 million against loss before income taxes, earnings from unconsolidated investees, and noncontrolling interest of $21.925 million a year ago. Net income attributable to the company was $8.727 million or $0.80 per diluted share against net loss attributable to the company of $17.452 million or $1.64 per diluted share a year ago. Net cash provided by operating activities was $68.992 million against $65.119 million a year ago. Equipment purchases were $23.194 million against $19.096 million a year ago. Adjusted EBITDA was $104.574 million against $112.302 million a year ago. Net income was $7.854 million against $1.332 million a year ago. Net debt was $466.479 million at September 30, 2014. For the third quarter ended September 30, 2014, the company reported impairment charges of $4,000, compared to $4,529,000 a year ago. The company narrows 2014 guidance ranges principally due to the timing of new Alliance Oncology and Alliance RAD360(TM) projects. The company expects revenue in the range of $437 million - $442 million against previous guidance of $437 - $462 million, Adjusted EBITDA of $140 - $145 million against previous guidance of $140 - $160 million and capital expenditure of $40 - $50 million against previous guidance of $52 - $62 million. Free cash flow guidance range is a range from $27 million to $37 million.

Alliance Healthcare Services, Inc. to Report Q3, 2014 Results on Nov 06, 2014

Alliance Healthcare Services, Inc. announced that they will report Q3, 2014 results at 5:00 PM, Eastern Standard Time on Nov 06, 2014

Alliance Healthcare Services, Inc., Q3 2014 Earnings Call, Nov 06, 2014

Alliance Healthcare Services, Inc., Q3 2014 Earnings Call, Nov 06, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AIQ:US $22.54 USD -1.30

AIQ Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Enzo Biochem Inc $3.15 USD +0.02
NeoGenomics Inc $4.03 USD +0.06
Psychemedics Corp $14.96 USD -0.03
RadNet Inc $7.89 USD -0.33
Response Genetics Inc $0.43 USD +0.0107
View Industry Companies
 

Industry Analysis

AIQ

Industry Average

Valuation AIQ Industry Range
Price/Earnings 54.9x
Price/Sales 0.6x
Price/Book NM Not Meaningful
Price/Cash Flow 3.6x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALLIANCE HEALTHCARE SERVICE, please visit www.alliancehealthcareservices-us.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.